Latest Breaking News On - Pravesh khandelwal - Page 6 : comparemela.com

Embecta Corp Reports First Quarter Fiscal 2023 Financial Results

PARSIPPANY, N.J., Feb. 14, 2023 (GLOBE NEWSWIRE) Embecta Corp. ("embecta" or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial

United statesPravesh khandelwalDennis riedlChristian glazarHealth care professionals hcpsEmbecta corpCompany nasdaqCompany board of directorsExchange commissionUs food drug administrationCorporate communicationsChief executive officerQuarter fiscal yearCare professionalsBreakthrough device designationSeparation date

embecta to Participate in Upcoming Investor Conferences

embecta to Participate in Upcoming Investor Conferences
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPravesh khandelwalChristian glazarsrEmbecta corpCorporate communicationsTechnology conferenceGlobal high yieldLeveraged financeAnnual healthcareInvestor relationsContact media

embecta to Report Fiscal First Quarter 2023 Financial Results

embecta to Report Fiscal First Quarter 2023 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Pravesh khandelwalChristian glazarsrEmbecta corpCorporate communicationsInvestor relationsContact media

embecta opens new global headquarters in Parsippany, N J

PARSIPPANY, N.J., Jan. 25, 2023 (GLOBE NEWSWIRE) Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the.

United statesNew jerseyPravesh khandelwalPhil murphyChristian glazarEmbecta corpCorporate communicationsNorth americaGarden stateGovernor philNasdaq embcEmbecta corp

Embecta Corp Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results

20.12.2022 - PARSIPPANY, N.J., Dec. 20, 2022 (GLOBE NEWSWIRE) - Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial results for the three and twelve month periods ended .

United statesPravesh khandelwalChristian glazarExchange commissionEmbecta corpUs food drug administrationCompany board of directorsCorporate communicationsEuropean union medical device regulationQuarter fiscal yearMonths ended septemberIntuity medicalBlood glucose monitoring systemBreakthrough device designationMonths fiscal yearFiscal year